Recently, a hot line presentation revealed primary results from ACACIA-HCM study, focusing on patients with non-obstructive hypertrophic cardiomyopathy. The presentation aimed at elaborating on the favorable topline results. Key statistics from the study were shared, showcasing the positive outcomes in this specific patient population. This presentation provided further insights into the effectiveness of the treatment in improving the condition of individuals with non-obstructive hypertrophic cardiomyopathy.